Stocks moved in choppy trade amid a array of corporate headlines and policy-driven headlines. According to CNBC, Apple shares fell about 4% after Nikkei Asia reported setbacks in the engineering test phase for the iPhone’s foldable version, a development that could complicate mass production and shipments.
Universal Music Group, the U.S.-listed arm of the London-based music giant, vaulted nearly 13% on news that Pershing Square Capital Management, led by Bill Ackman, has proposed to acquire the company in a cash-and-stock deal valued at about €55.8 billion ($64.4 billion). Arm Holdings meanwhile slid more than 4% after Morgan Stanley downgraded the stock to equal weight from overweight, citing the time needed for its strategic pivot toward chips amid the AI buildout and near-term risks such as higher research and development costs and dynamic RAM shortages.
In AI hardware news, Broadcom rose about 4% after announcing it would supply artificial intelligence chips for Google and after signing an expanded deal with Anthropic to provide roughly 3.5 gigawatts of computing capacity drawn from Google’s AI processors. Alphabet edged higher by about 0.9%. Oil-related names were broadly higher as crude prices stayed elevated, with WTI futures trading above $114 a barrel ahead of a reported presidential threat to attack Iran’s civil infrastructure by 8 p.m. ET on Tuesday. Chevron gained more than 1%, and Diamondback Energy was up roughly 2%.
Healthcare stocks rallied following the Centers for Medicare and Medicaid Services’ finalization of a proposed payment increase to privately run Medicare Advantage plans, a change higher than initially proposed in January. UnitedHealth Group surged around 10%, while Humana rose about 8% and CVS Health gained roughly 7%.
Travel-related equities faced pressure as oil stayed elevated, with cruise operators and airlines broadly softening. Norwegian Cruise Line dropped more than 5%, while Carnival and Royal Caribbean advanced about 4%. Among airlines, United Airlines rose about 3.5%, American Airlines about 2%, and Delta Air Lines around 1.5%.
Key takeaways
- Apple shares fell about 4% as investors weighed a Nikkei Asia report of setbacks in the foldable iPhone’s engineering tests, which could delay mass production and shipments. Implication: potential pressure on product cadence and supplier timelines.
- Universal Music Group shares jumped roughly 13% on a bid approach from Pershing Square, valuing the deal at about €55.8 billion. Implication: a possible strategic re-rating for the company, with execution risk and regulatory review to follow.
- Arm Holdings declined more than 4% after Morgan Stanley downgraded the stock to equal weight from overweight. Implication: investors may price-in longer timelines for AI-driven chip adoption and higher near-term R&D costs amid DRAM supply dynamics.
- Broadcom and Alphabet advanced on AI-related deals, with Broadcom up about 4% on AI-chip supply for Google and a broader Anthropic relationship, while Alphabet rose about 0.9%. Implication: AI infrastructure demand remains a focal point for chipmakers and software platforms alike.
- Medicare Advantage momentum boosted insurer names after CMS finalized a higher proposed payment increase for privately run Medicare Advantage plans. UnitedHealth led gains, jumping around 10%, with Humana and CVS Health rising in the high single digits. Implication: near-term earnings visibility for major insurers improves on policy support.
What drove the move
The session’s headlines centered on the trajectory of AI-related spending and policy shifts that affect healthcare payments and the energy complex. The Apple development weighs on investors’ outlook for device launches and supply-chain timing, especially given the broader push into foldable and flexible-screen ecosystems. The Pershing Square bid for Universal Music introduces the potential for a transformative ownership shake-up in the music distribution space, reinforcing sentiment that noncore assets may become targets in a cyclical market.
Arm’s downgrade highlights the market’s sensitivity to the pace of AI-enabled chip adoption and the associated costs. Morgan Stanley cautioned that Arm’s shift toward processors to support AI workloads may take time and come with higher upfront costs, a dynamic that could temper near-term earnings momentum for the stock.
On the AI hardware frontier, Broadcom’s confirmed supply relationship with Google and its expanded engagement with Anthropic underscore a continued push by major chipmakers to monetize AI compute infrastructure, a trend that has become a sustained driver for the sector’s performance. Alphabet’s modest gains suggest investors are weighing the company’s long-run AI ambitions against near-term macro and policy risks.
Policy movements in healthcare provided a counterbalance to tech softness. With CMS’s finalized Medicare Advantage payment increase, insurers appeared to receive a more favorable policy backdrop than previously anticipated, supporting a broad rally in the sector. The gains in UnitedHealth, Humana, and CVS Health reflect a tilt toward defensives within the health care complex, even as the sector’s performance can be highly idiosyncratic around contract terms and plan mix.
Market reaction
The session illustrated the typical dispersion across sectors as investors rotated between growth-oriented AI exposure and more policy-driven defensives. While technology and AI-capital equipment names offered mixed signals, healthcare logistics and policy certainty provided pockets of strength. Energy equities, supported by a stubbornly firm oil backdrop, contributed to continued market rotation as traders assessed geopolitics and potential supply disruptions.
What analysts are saying
Analysts cited the Morgan Stanley downgrade of Arm as a key driver of volatility in the AI chip space, noting that the near-term path to profitability from Arm’s chip-centric pivot remains uncertain and is subject to cost and supply constraints. Beyond that, the commentary centered on policy-driven tailwinds for insurers following CMS’s updated Medicare Advantage payments and the continued interest in AI compute capacity from major chip and cloud players, which could color the pace of capital expenditure and the level of outsourcing within the sector.
Bigger picture
Investors are navigating an environment where AI-driven demand continues to shape earnings trajectories for semiconductor and cloud-related names, even as execution risk and supply-chain dynamics inject volatility. The healthcare policy backdrop offers a degree of earnings visibility for insurers, while geopolitical risk remains a factor for energy equities and the broader market. The earnings calendar and central-bank communications in the coming weeks will likely influence whether the current rotation persists or reverses further.
For markets to maintain momentum, observers will be watching for updates on Apple’s foldable roadmap, any development in Pershing Square’s approach to Universal Music, Arm’s progress in delivering on its AI strategy, and the sustainability of CMS’s Medicare Advantage policy impact. The evolving macro backdrop—ranging from inflation data and Fed expectations to energy price movements and geopolitical risk—will continue to shape how investors price these interconnected themes.
Closing what-to-watch next: traders will look for fresh commentary on AI infrastructure demand, the pace of AI-capex in the cloud and semiconductor ecosystems, and any regulatory or policy shifts that could alter earnings trajectories for the healthcare and energy complexes. Earnings releases, policy updates, and global macro data over the coming weeks will be critical to setting the tone for the next leg of the market’s rotation.
